Gauthier S, Albert M, Fox N, Goedert M, Kivipelto M, Mestre-Ferrandiz J, et al. Why has remedy improvement for dementia failed within the final 20 years? Alzheimers Dement. 2016;12(1):60–4.
Ferreira D, Rivero-Santana A, Perestelo-Pérez L, Westman E, Wahlund L-O, Sarría A, et al. Enhancing CSF biomarkers’ efficiency for predicting development from delicate cognitive impairment to Alzheimer’s illness by contemplating completely different confounding components: a meta-analysis. Entrance Growing old Neurosci. 2014;6:287.
Ruan Q, D’Onofrio G, Sancarlo D, Bao Z, Greco A, Yu Z. Potential neuroimaging biomarkers of pathologic mind modifications in Delicate Cognitive Impairment and Alzheimer’s illness: a scientific overview. BMC Geriatr. 2016;16(1):1–9.
Dunne RA, Aarsland D, O’Brien JT, Ballard C, Banerjee S, Fox NC, et al. Delicate cognitive impairment: the Manchester consensus. Age Ageing. 2021;50(1):72–80.
Belleville S, Fouquet C, Hudon C, Zomahoun HTV, Croteau J. Neuropsychological measures that predict development from delicate cognitive impairment to Alzheimer’s sort dementia in older adults: a scientific overview and meta-analysis. Neuropsychol Rev. 2017;27(4):328–53.
Lombardi G, Crescioli G, Cavedo E, Lucenteforte E, Casazza G, Bellatorre AG, et al. Structural magnetic resonance imaging for the early prognosis of dementia because of Alzheimer’s illness in folks with delicate cognitive impairment. Cochrane Database Syst Rev. 2020(3).
Watermeyer T, Calia C. Neuropsychological evaluation in preclinical and prodromal Alzheimer illness: a worldwide perspective. J World Well being. 2019;9(1).
Smart EA, Rosenberg PB, Lyketsos CG, Leoutsakos J-M. Time course of neuropsychiatric signs and cognitive prognosis in Nationwide Alzheimer’s Coordinating Facilities volunteers. Alzheimers Dement (Amst). 2019;11:333–9.
Taragano FE, Allegri RF, Krupitzki H, Sarasola D, Serrano C, Lyketsos C. Delicate behavioral impairment. J Clin Psychiatry. 2009;70(4):584–92.
Ismail Z, Smith EE, Geda Y, Sultzer D, Brodaty H, Smith G, et al. Neuropsychiatric signs as early manifestations of emergent dementia: provisional diagnostic standards for delicate behavioral impairment. Alzheimers Dement. 2016;12(2):195–202.
Jack CR Jr, Bennett DA, Blennow Ok, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA analysis framework: towards a organic definition of Alzheimer’s illness. Alzheimers Dement. 2018;14(4):535–62.
Ismail Z, McGirr A, Gill S, Hu S, Forkert ND, Smith EE. Delicate Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Purposeful Decline. J Alzheimers Dis. 2021;80(1):459–69.
McGirr A, Nathan S, Ghahremani M, Gill S, Smith EE, Ismail Z. Development to Dementia or Reversion to Regular Cognition in Delicate Cognitive Impairment as a Perform of Late-Onset Neuropsychiatric Signs. Neurology. 2022;98(21):e2132–9.
Creese B, Brooker H, Ismail Z, Wesnes KA, Hampshire A, Khan Z, et al. Delicate Behavioral Impairment as a Marker of Cognitive Decline in Cognitively Regular Older Adults. Am J Geriatr Psychiatry. 2019;27(8):823–34.
Kan CN, Cano J, Zhao X, Ismail Z, Chen CL, Xu X. Prevalence, Scientific Correlates, Cognitive Trajectories, and Dementia Threat Related With Delicate Behavioral Impairment in Asians. J Clin Psychiatry. 2022;83(3):40123.
Matsuoka T, Ismail Z, Narumoto J. Prevalence of delicate behavioral impairment and danger of dementia in a psychiatric outpatient clinic. J Alzheimers Dis. 2019;70(2):505–13.
Ruthirakuhan M, Ismail Z, Herrmann N, Gallagher D, Lanctot KL. Delicate behavioral impairment is related to development to Alzheimer’s illness: A clinicopathological research. Alzheimers Dement. 2022;in press.
Tsunoda Ok, Yamashita T, Osakada Y, Sasaki R, Tadokoro Ok, Matsumoto N, et al. Constructive baseline behavioral and psychological signs of dementia predict a subsequent cognitive impairment in cognitively regular inhabitants. Neurol Clin Neurosci. 2021;9(3):218–22.
Wolfova Ok, Creese B, Aarsland D, Ismail Z, Corbett A, Ballard C, et al. Gender/Intercourse Variations within the Affiliation of Delicate Behavioral Impairment with Cognitive Growing old. J Alzheimers Dis. 2022;88(1):345–55.
Gill S, Mouches P, Hu S, Rajashekar D, MacMaster FP, Smith EE, et al. Utilizing Machine Studying to Predict Dementia from Neuropsychiatric Symptom and Neuroimaging Information. J Alzheimers Dis. 2020;75(1):277–88.
Ebrahim IM, Ghahremani M, Camicioli R, Smith EE, Ismail Z. Results of race, baseline cognition, and APOE on the affiliation of affective dysregulation with incident dementia: A longitudinal research of dementia-free older adults. J Have an effect on Disord. 2023;332:9–18.
Ismail Z, Ghahremani M, Amlish Munir M, Fischer CE, Smith EE, Creese B. A longitudinal research of late-life psychosis and incident dementia and the potential results of race and cognition. Nat Psychological Well being. 2023;1(4):273–83.
Yoon EJ, Lee J-Y, Kwak S, Kim YK. Delicate behavioral impairment linked to development to Alzheimer’s illness and cortical thinning in amnestic delicate cognitive impairment. Entrance Growing old Neurosci. 2023;14.
Rouse HJ, Ismail Z, Andel R, Molinari VA, Schinka JA, Small BJ. Affect of Delicate Behavioral Impairment on Longitudinal Modifications in Cognition. J Gerontol: Sequence A. 2023:glad098.
Creese B, Arathimos R, Aarsland D, Ballard C, Brooker H, Hampshire A, et al. Late-life onset psychotic signs and incident cognitive impairment in folks with out dementia: Modification by genetic danger for Alzheimer’s illness. Alzheimer’s & Dementia: Translational Analysis & Scientific Interventions. 2023;9(2): e12386.
Johansson M, Stomrud E, Insel PS, Leuzy A, Johansson PM, Smith R, et al. Delicate behavioral impairment and its relation to tau pathology in preclinical Alzheimer’s illness. Transl Psychiatr. 2021;11(1):76.
Lussier FZ, Pascoal TA, Chamoun M, Therriault J, Tissot C, Savard M, et al. Delicate behavioral impairment is related to β-amyloid however not tau or neurodegeneration in cognitively intact aged people. Alzheimers Dement. 2020;16(1):192–9.
Miao R, Chen HY, Gill S, Naude J, Smith EE, Ismail Z, et al. Plasma beta-Amyloid in Delicate Behavioural Impairment – Neuropsychiatric Signs on the Alzheimer’s Continuum. J Geriatr Psychiatry Neurol. 2022;35(3):434–41.
Dufouil C, Dubois B, Vellas B, Pasquier F, Blanc F, Hugon J, et al. Cognitive and imaging markers in non-demented topics attending a reminiscence clinic: research design and baseline findings of the MEMENTO cohort. Alzheimers Res Ther. 2017;9(1):67.
Cummings J. The Neuropsychiatric Stock: Growth and Purposes. J Geriatr Psychiatry Neurol. 2020;33(2):73–84.
Sheikh F, Ismail Z, Mortby ME, Barber P, Cieslak A, Fischer Ok, et al. Prevalence of delicate behavioral impairment in delicate cognitive impairment and subjective cognitive decline, and its affiliation with caregiver burden. Int Psychogeriatr. 2018;30(2):233–44.
Howard AL. Leveraging time-varying covariates to check within-and between-person results and interactions within the multilevel linear mannequin. Emerg Maturity. 2015;3(6):400–12.
Moussa C, Hebron M, Huang X, Ahn J, Rissman RA, Aisen PS, et al. Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s illness. J Neuroinflammation. 2017;14(1):1–10.
Noguchi-Shinohara M, Komatsu J, Samuraki M, Matsunari I, Ikeda T, Sakai Ok, et al. Cerebral amyloid angiopathy-related microbleeds and cerebrospinal fluid biomarkers in Alzheimer’s illness. J Alzheimers Dis. 2017;55(3):905–13.
Hellström-Lindahl E, Mousavi M, Ravid R, Nordberg A. Decreased ranges of Aβ 40 and Aβ 42 in brains of smoking controls and Alzheimer’s sufferers. Neurobiol Dis. 2004;15(2):351–60.
Walsh P, Sudre CH, Fiford CM, Ryan NS, Lashley T, Frost C, et al. The age-dependent associations of white matter hyperintensities and neurofilament gentle in early-and late-stage Alzheimer’s illness. Neurobiol Growing old. 2021;97:10–7.
Miao R, Chen H-Y, Robert P, Smith EE, Ismail Z, Group MS. White matter hyperintensities and delicate behavioral impairment: Findings from the MEMENTO cohort research. Cerebral Circulation-Cognition and Habits. 2021;2: 100028.
Fukuyama R, Mizuno T, Mizuno T, Mori S, Nakajima Ok, Fushiki S, et al. Age-dependent change within the ranges of Aβ40 and Aβ42 in cerebrospinal fluid from management topics, and a lower within the ratio of Aβ42 to Aβ40 stage in cerebrospinal fluid from Alzheimer’s illness sufferers. Eur Neurol. 2000;43(3):155–60.
Hansson O, Zetterberg H, Buchhave P, Andreasson U, Londos E, Minthon L, et al. Prediction of Alzheimer’s illness utilizing the CSF Aβ42/Aβ40 ratio in sufferers with delicate cognitive impairment. Dement Geriatr Cogn Disord. 2007;23(5):316–20.
Showraki A, Murari G, Ismail Z, Barfett JJ, Fornazzari L, Munoz DG, et al. Cerebrospinal Fluid Correlates of Neuropsychiatric Signs in Sufferers with Alzheimer’s Illness/Delicate Cognitive Impairment: A Systematic Assessment. J Alzheimers Dis. 2019;71(2):477–501.
Ghahremani M, Wang M, Chen H-Y, Zetterberg H, Smith E, Ismail Z, et al. Plasma Phosphorylated Tau at Threonine 181 and Neuropsychiatric Signs in Preclinical and Prodromal Alzheimer Illness. Neurology. 2023;100(7):e683–93.
Ismail Z, Aguera-Ortiz L, Brodaty H, Cieslak A, Cummings J, Fischer CE, et al. The Delicate Behavioral Impairment Guidelines (MBI-C): A Ranking Scale for Neuropsychiatric Signs in Pre-Dementia Populations. J Alzheimers Dis. 2017;56(3):929–38.
Hansson O, Seibyl J, Stomrud E, Zetterberg H, Trojanowski JQ, Bittner T, et al. CSF biomarkers of Alzheimer’s illness harmony with amyloid-β PET and predict scientific development: a research of absolutely automated immunoassays in BioFINDER and ADNI cohorts. Alzheimers Dement. 2018;14(11):1470–81.
Santangelo R, Masserini F, Agosta F, Sala A, Caminiti SP, Cecchetti G, et al. CSF p-tau/Aβ 42 ratio and mind FDG-PET could reliably detect MCI “imminent” converters to AD. Eur J Nucl Med Mol Imaging. 2020:1–13.
Naude JP, Gill S, Hu S, McGirr A, Forkert ND, Monchi O, et al. Plasma Neurofilament Mild: A Marker of Neurodegeneration in Delicate Behavioral Impairment. J Alzheimers Dis. 2020;76(3):1017–27.
Kassam F, Chen H, Nosheny RL, McGirr A, Williams T, Ng N, et al. Cognitive profile of individuals with delicate behavioral impairment in Mind Well being Registry contributors. Int Psychogeriatr. 2022;in press:1–10.
Rouse HJ, Small BJ, Schinka JA, Loewenstein DA, Duara R, Potter H. Delicate behavioral impairment as a predictor of cognitive functioning in older adults. Int Psychogeriatr. 2021;33(3):285–93.
Andrews SJ, Ismail Z, Anstey KJ, Mortby M. Affiliation of Alzheimer’s genetic loci with delicate behavioral impairment. Am J Med Genet B Neuropsychiatr Genet. 2018;177(8):727–35.
Creese B, Arathimos R, Brooker H, Aarsland D, Corbett A, Lewis C, et al. Genetic danger for Alzheimer’s illness, cognition, and delicate behavioral impairment in wholesome older adults. Alzheimers Dement (Amst). 2021;13(1): e12164.
Gill S, Wang M, Mouches P, Rajashekar D, Sajobi T, MacMaster FP, et al. Neural correlates of the impulse dyscontrol area of delicate behavioral impairment. Int J Geriatr Psychiatry. 2021;36(9):1398–406.
Matuskova V, Ismail Z, Nikolai T, Markova H, Cechova Ok, Nedelska Z, et al. Delicate behavioral impairment is related to atrophy of entorhinal cortex and hippocampus in a reminiscence clinic cohort. Frontiers in Growing old Neuroscience. 2021;13:236.
Matsuoka T, Imai A, Narumoto J. Neuroimaging of delicate behavioral impairment: A scientific overview. Psychiatry and Scientific Neurosciences Stories. 2023;2(1): e81.
Taragano FE, Allegri RF, Heisecke SL, Martelli MI, Feldman ML, Sánchez V, et al. Threat of Conversion to Dementia in a Delicate Behavioral Impairment Group In comparison with a Psychiatric Group and to a Delicate Cognitive Impairment Group. J Alzheimers Dis. 2018;62:227–38.
Creavin ST, Wisniewski S, Noel‐Storr AH, Trevelyan CM, Hampton T, Rayment D, et al. Mini‐Psychological State Examination (MMSE) for the detection of dementia in clinically unevaluated folks aged 65 and over in group and first care populations. The Cochrane Library. 2016.
Creese B, Griffiths A, Brooker H, Corbett A, Aarsland D, Ballard C, et al. Profile of delicate behavioral impairment and issue construction of the Delicate Behavioral Impairment Guidelines in cognitively regular older adults. Int Psychogeriatr. 2020;32(6):705–17.
Cui Y, Dai S, Miao Z, Zhong Y, Liu Y, Liu L, et al. Reliability and Validity of the Chinese language Model of the Delicate Behavioral Impairment Guidelines for Screening for Alzheimer’s Illness. J Alzheimers Dis. 2019;70(3):747–56.
Hu S, Patten S, Charlton A, Fischer Ok, Fick G, Smith EE, et al. Validating the Delicate Behavioral Impairment Guidelines in a Cognitive Clinic: Comparisons With the Neuropsychiatric Stock Questionnaire. J Geriatr Psychiatry Neurol. 2022:8919887221093353.
Lin RS, Yu DS, Chau PH, Li PW, Ismail Z. Reliability and Validity of the Conventional Chinese language Model of the Delicate Behavioral Impairment–Guidelines Amongst Individuals With Delicate Cognitive Impairment–A Validation Research. J Geriatr Psychiatry Neurol. 2022:08919887221093363.
Mallo SC, Ismail Z, Pereiro AX, Facal D, Lojo-Seoane C, Campos-Magdaleno M, et al. Assessing delicate behavioral impairment with the Delicate behavioral impairment-checklist in folks with delicate cognitive impairment. J Alzheimers Dis. 2018;66(1):83–95.
Mallo SC, Ismail Z, Pereiro AX, Facal D, Lojo-Seoane C, Campos-Magdaleno M, et al. Assessing delicate behavioral impairment with the delicate behavioral impairment guidelines in folks with subjective cognitive decline. Int Psychogeriatr. 2019;31(2):231–9.
Xu L, Li T, Xiong L, Wang X, Ismail Z, Fukuda M, et al. Reliability and Validity of the Chinese language Model of Delicate Behavioral Impairment Guidelines in Delicate Cognitive Impairment and Delicate Alzheimer’s Illness. J Alzheimers Dis. 2021;81(3):1141–9.
Saari T, Smith EE, Ismail Z. Community evaluation of impulse dyscontrol in delicate cognitive impairment and subjective cognitive decline. Int Psychogeriatr. 2022;34(6):553–62.
Pépin É, Tanguay N, Roy M-P, Macoir J, Bruneau M-A, Ismail Z, et al. Preliminary Validation Research of the French-Quebec Model of the Delicate Behavioral Impairment Guidelines. Cogn Behav Neurol. 2022:10.1097.
Matsuoka T, Ueno D, Ismail Z, Rubinstein E, Uchida H, Mimura M, et al. Neural Correlates of Delicate Behavioral Impairment: A Purposeful Mind Connectivity Research Utilizing Resting-State Purposeful Magnetic Resonance Imaging. J Alzheimers Dis. 2021;83(3):1221–31.
